Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups

Journal of the National Medical Association

Volumn 99, Issue 10, 2007, Pages 1196-1198

  Durán, Sergio ^a   Apte, Mandar ^a   Alarcón, Graciela S ^a,b  

^a The University of Alabama at Birmingham   (United States)

^b 830 Faculty Office Tower ^*  (United States)

Author keywords

Lupus; Race ethnicity; Socioeconomic status

Indexed keywords

ADULT; AFRICAN AMERICAN; EDITORIAL; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE DISTRIBUTION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POVERTY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; ETHNIC GROUPS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POVERTY; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIAL CLASS; SURVIVAL RATE; UNITED STATES;

EID: 35349013572     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (27)

1. Anstey NM, Bastian I, Dunckley H, et al. Systemic lupus erythematosus in Australian Aborigines: high prevalence, morbidity and mortality. Aust N Z J Med. 1993;23:646-651.
2. Hernández-Cruz B, Tapia N, Villa-Romero AR, et al. Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin Exper Rheumatol. 2001;19:395-401.
3. Kumar A, Malaviya AN, Singh RR, et al. Survival in patients with systemic lupus erythematosus in India. Rheumatol Intl. 1992;12:107-109.
4. Huicochea Grobet ZL, Berron R, Ortega Martell JA, et al. Survival up to 5 and 10 years of Mexican pediatric patients with systemic lupus erythematosus. Overhaul of 23 years experience. Allergol Immunopathol. 1996;24:36-38.
5. Urowitz MB, Gladman DD, Abu-Shakra M, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol. 1997;24:1061-1065.
6. Sacks JJ, Helmick CG, Langmaid G, et al. Trends in deaths from systemic lupus erythematosus-United States, 1979-1998. MMWR. 2002;51:371-374.
7. Pew Hispanic Center. Hispanics a people in motion. Trends. 2005;accessed at http://pewresearch.org/assets/files/trends2005-hispanic.pdf.
8. Siegel M, Holley HL, Lee SL. Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum. 1970;13:802-811.
9. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990;33:37-48.
10. Walsh SJ, Algert C, Gregorio DI, et al. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol. 1995;22:1663-1668.
11. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25:601-611.
12. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 1995;38:274-283.
13. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore). 2006;85:147-156.
14. Alarcon GS, McGwin G Jr, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum. 2001;45:191-202.
15. Fernandez M, Alarcon GS, Calvo-Alen J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007;57:576-584.
16. Alarcon GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. Arthritis Rheum. 1998;41:1173-1180.
17. Alarcon GS, Calvo-Alen J, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006;1168-1174.
18. Behrens TW, Graham RR, Kyogoku C, et al. Progress towards understanding the genetic pathogenesis of systemic lupus erythematosus. Novartis Found Symp. 2005;267:145-160.
19. Alarcon-Riquelme ME. The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility. Springer Semin Immunopathol. 2006;28:109-117.
20. Graham RR, Kozyrev SV, Baechler EC, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006;38:550-555.
21. Alarcon GS, McGwin G Jr, Petri M, et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med. 2006;3:e396.
22. Rodriguez RA, Sen S, Mehta K, et al. Geography matters: relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med. 2007;146:493-501.
23. Gold R, Michael YL, Whitlock EP, et al. Race/ethnicity, socioeconomic status, and lifetime morbidity burden in the women's health initiative: a cross-sectional analysis. J Womens Health (Larchmt). 2006;15:1161-1173.
24. Walsh SJ, Dechello LM. Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus. 2001;10:637-646.
25. Centers for Disease Control and Prevention. National health interview survey, health insurance supplements (1984, 1989, 1994-1996). www.cdc.gov/nchs/hus.htm.
26. Passel JS. Size and characteristics of the unauthorized migrant population in the United States. http://pewhispanic.org/reports/report.php? ReportID=61.
27. U.S. Department of Health and Human Services. Disparities in health care. AHRQ (Agency for Healthcare Research and Quality). 2002;Pub. No. 02-M027.